JP2006519823A5 - - Google Patents

Download PDF

Info

Publication number
JP2006519823A5
JP2006519823A5 JP2006505920A JP2006505920A JP2006519823A5 JP 2006519823 A5 JP2006519823 A5 JP 2006519823A5 JP 2006505920 A JP2006505920 A JP 2006505920A JP 2006505920 A JP2006505920 A JP 2006505920A JP 2006519823 A5 JP2006519823 A5 JP 2006519823A5
Authority
JP
Japan
Prior art keywords
pain
pharmaceutical composition
composition according
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006505920A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006519823A (ja
Filing date
Publication date
Priority claimed from GBGB0305149.7A external-priority patent/GB0305149D0/en
Application filed filed Critical
Publication of JP2006519823A publication Critical patent/JP2006519823A/ja
Publication of JP2006519823A5 publication Critical patent/JP2006519823A5/ja
Pending legal-status Critical Current

Links

JP2006505920A 2003-03-07 2004-03-05 疼痛治療のための化合物 Pending JP2006519823A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0305149.7A GB0305149D0 (en) 2003-03-07 2003-03-07 Compounds for the treatment of pain
PCT/GB2004/000935 WO2004078183A1 (en) 2003-03-07 2004-03-05 Compounds for the treatment of pain

Publications (2)

Publication Number Publication Date
JP2006519823A JP2006519823A (ja) 2006-08-31
JP2006519823A5 true JP2006519823A5 (cg-RX-API-DMAC7.html) 2011-06-02

Family

ID=9954247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505920A Pending JP2006519823A (ja) 2003-03-07 2004-03-05 疼痛治療のための化合物

Country Status (19)

Country Link
US (1) US7759321B2 (cg-RX-API-DMAC7.html)
EP (1) EP1603577B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006519823A (cg-RX-API-DMAC7.html)
KR (1) KR20050115273A (cg-RX-API-DMAC7.html)
CN (1) CN100579533C (cg-RX-API-DMAC7.html)
AT (1) ATE401087T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004216889B2 (cg-RX-API-DMAC7.html)
CA (1) CA2514098A1 (cg-RX-API-DMAC7.html)
CY (1) CY1108416T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004015085D1 (cg-RX-API-DMAC7.html)
DK (1) DK1603577T3 (cg-RX-API-DMAC7.html)
ES (1) ES2310288T3 (cg-RX-API-DMAC7.html)
GB (1) GB0305149D0 (cg-RX-API-DMAC7.html)
NO (1) NO20054476L (cg-RX-API-DMAC7.html)
NZ (1) NZ541521A (cg-RX-API-DMAC7.html)
PL (1) PL1603577T3 (cg-RX-API-DMAC7.html)
PT (1) PT1603577E (cg-RX-API-DMAC7.html)
SI (1) SI1603577T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004078183A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305153D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Identification of therapeutic compounds
GB0305150D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Use of therapeutic compounds
KR20070004792A (ko) * 2004-03-05 2007-01-09 캠브리지 바이오테크놀로지 리미티드 아데노신 수용체 작용제
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
US8512984B2 (en) 2004-12-01 2013-08-20 Syntaxin, Ltd. Non-cytotoxic protein conjugates
US8603779B2 (en) 2004-12-01 2013-12-10 Syntaxin, Ltd. Non-cytotoxic protein conjugates
US8778634B2 (en) 2004-12-01 2014-07-15 Syntaxin, Ltd. Non-cytotoxic protein conjugates
US8399400B2 (en) * 2004-12-01 2013-03-19 Syntaxin, Ltd. Fusion proteins
GB0426394D0 (en) * 2004-12-01 2005-01-05 Health Prot Agency Fusion proteins
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CN1947717B (zh) * 2005-10-14 2012-09-26 卓敏 选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
GB0610867D0 (en) * 2006-06-01 2006-07-12 Syntaxin Ltd Treatment of pain
US7906518B2 (en) 2006-06-27 2011-03-15 Cbt Development Limited Therapeutic compounds
NZ573308A (en) * 2006-06-27 2012-02-24 Biovitrum Ab Publ Adenosine derivatives for the treatment of pain
CN101479268B (zh) 2006-06-27 2012-08-08 Cbt发展有限公司 2-0’-甲基腺苷衍生物及其用作制备腺苷受体的激动剂或拮抗剂的应用
US20140056870A1 (en) 2012-08-27 2014-02-27 Allergan, Inc. Fusion proteins
CN103342727A (zh) * 2013-07-01 2013-10-09 淮海工学院 一种2-甲氧基腺苷的合成方法
JP6440240B2 (ja) * 2014-02-19 2018-12-19 国立大学法人富山大学 末梢神経障害誘発感覚異常を改善する外用剤
US12336977B2 (en) * 2019-07-31 2025-06-24 Sea4Us—Biotecnologia E Recursos Marinhos, Lda. Nitenin analogue compounds and their use in the treatment of chronic and acute pain

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792155A (fr) * 1971-12-01 1973-05-30 Takeda Chemical Industries Ltd Nouveaux derives de l'adenosine et leur procede de production
JPS4861498A (cg-RX-API-DMAC7.html) 1971-12-01 1973-08-28
DE2359536C2 (de) 1972-12-08 1984-08-02 Takeda Chemical Industries, Ltd., Osaka 2,6-Diaminonebularinderivate
JPS5461194A (en) 1977-10-21 1979-05-17 Takeda Chem Ind Ltd Preparation of n22substituted 2*66diaminonebularin
JPS5461195A (en) 1977-10-21 1979-05-17 Takeda Chem Ind Ltd N2-substituted phenyl-2,6-diaminonebularin
US4705758A (en) 1984-06-19 1987-11-10 Warner-Lambert Company Adenosine receptor assay and kit
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5683989A (en) * 1993-12-17 1997-11-04 Novo Nordisk A/S Treatment of ischemias by administration of 2,N6 -substituted adenosines
PL316985A1 (en) * 1994-05-10 1997-03-03 Sandoz Ltd Derivatives of adenosine
US5877180A (en) 1994-07-11 1999-03-02 University Of Virginia Patent Foundation Method for treating inflammatory diseases with A2a adenosine receptor agonists
IT1275420B (it) 1995-06-02 1997-08-05 Schering Plough S P A Metodo per misurare l'affinita' di legame al recettore a2a dell'adenosina di componenti di interesse farmacologico mediante l'uso del ligando triziato (3h)-sch 58261
JP2002500188A (ja) 1998-01-08 2002-01-08 ザ・ユニバーシティ・オブ・バージニア・パテント・ファウンデーション A2aアデノシンレセプター作動因子
GB0228723D0 (en) * 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305153D0 (en) 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Identification of therapeutic compounds

Similar Documents

Publication Publication Date Title
JP2011132229A5 (cg-RX-API-DMAC7.html)
CN100579533C (zh) 治疗疼痛的化合物
JP4836454B2 (ja) 疼痛、特に痛覚過敏治療のための、スポンゴシン(2−メトキシアデノシン)の使用。
JP2017522352A5 (cg-RX-API-DMAC7.html)
JP2006514638A5 (cg-RX-API-DMAC7.html)
EP1621195A3 (en) The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury
AU2007337089A1 (en) Alpha-2B receptor agonist and anticonvulsant compositions for treatng chronic pain
CN112118844B (zh) 含吲哚化合物的多发性硬化症治疗剂或预防剂
JP2021008496A (ja) インドール化合物を用いた疼痛又は間質性膀胱炎の治療方法
RU2013157928A (ru) Терапевтические средства для регуляции уровня фосфора в сыворотке
Wein et al. Diabetic neuropathies
ES2311537T3 (es) Utilizacion de nefiracetam en el tratamiento de la neurodegeneracion postquemica.
JP2022534794A5 (cg-RX-API-DMAC7.html)
ES2270981T3 (es) Procedimiento de tratamiento de la neurodegeneracion.
JP7527662B2 (ja) ピモジドとメトトレキサートの医薬組成物、及びその使用
JP2010536827A (ja) ある種の炎症性障害の治療に有用なカルボニルアミノ誘導体
CN116688135B (zh) 一种骨关节炎药物治疗组合物及其制备方法和应用
JP6857619B2 (ja) N−[7−[(メチルスルホニル)アミノ]−4−オキソ−6−フェノキシ−4h−1−ベンゾピラン−3−イル]ホルムアミドまたはその塩を含有する医薬組成物
WO2014034756A1 (ja) けいれん重積発作の治療用医薬組成物
EA008927B1 (ru) Применение производных 2h-[1,3]оксазино[3,2-a]индола для лечения невропатической боли
JP5699030B2 (ja) エタネルセプトを含む線維筋痛症の治療剤
HK1087629B (en) Compounds for the treatment of pain
CN1809356A (zh) 吲唑衍生物用于治疗神经病性疼痛的用途
CN114845722A (zh) 化合物在预防和/或治疗强直性脊柱炎中的应用和相应的组合物
Soliman et al. 25 patientsRamiKarroum